Crossmark

ASO Visual Abstract: Personalized Surgical Decision-Making Model for Clinical Stage IA Pure-Solid Non-Small Cell Lung Cancer

Published Online: 2025-11-28

Published Print: 2026-02

Authors

Yan, Haoji

Niimi, Takahiro

Matsunaga, Takeshi

Fukui, Mariko

Hattori, Aritoshi

Takamochi, Kazuya

Suzuki, Kenji
License Information

Text and Data Mining valid from 2025-11-28

Version of Record valid from 2025-11-28
More Information

Article History

First Online: 28 November 2025

Disclosure

: Kenji Suzuki received payments from Johnson & Johnson and Intuitive and held Thoracentes Inc stock. Kazuya Takamochi received payments from AstraZeneca, Chugai, Ono, and Covidien. There are no other conflicts of interest to disclose.

Free to read: This content has been made available to all.

Document is current